Back to Blog
ScienceSeptember 24, 2026

CGRP Migraine Treatments: What They Target and Who They May Help

CGRP-targeting medications were the first preventive treatments designed specifically for migraine. Here's what CGRP is, the different types of treatments, and who they're for.

For decades, migraine prevention relied on medications originally developed for other conditions: blood pressure drugs, antidepressants, and anti-seizure medications. Then came treatments targeting CGRP, the first preventive medications designed specifically for migraine.

What CGRP Is

CGRP (calcitonin gene-related peptide) is a protein released by trigeminal nerve endings. During migraine, CGRP levels rise. It widens blood vessels, promotes inflammation, and transmits pain signals. Blocking CGRP reduces migraine activity in many people.

For the science of how trigeminal nerves drive migraine, see our trigeminal nerve guide and vasodilation explainer.

Two Main Types

Monoclonal antibodies. These are lab-made antibodies that either bind CGRP itself or block its receptor. Examples include erenumab, fremanezumab, galcanezumab, and eptinezumab. Most are given as self-injections monthly or quarterly. Eptinezumab is given by IV infusion every three months.

Gepants. Small-molecule pills or sprays that block the CGRP receptor. Some treat attacks, some prevent them. See our plain-English guide to gepants.

Who They May Help

  • People with episodic or chronic migraine who need prevention
  • People who didn't respond to or couldn't tolerate older preventive medications
  • People with frequent attacks affecting work, family, or quality of life

Insurance requirements in some places mean you may need to try older preventives first.

What to Expect

In clinical trials, many people had a meaningful reduction in monthly migraine days, and some had a much larger response. Others didn't respond. It can take a few months to judge whether a treatment is working, so doctors usually recommend giving it time.

Side Effects

  • Injection-site reactions
  • Constipation, particularly with some antibodies
  • Possible blood pressure increases with some, so blood pressure is often monitored
  • Generally well tolerated in trials

Because CGRP is involved in blood vessel function, people with significant cardiovascular disease and those who are pregnant or planning pregnancy should discuss risks carefully with their doctor. Long-term data continues to accumulate.

Combining With Other Treatments

CGRP treatments are sometimes combined with other preventives, like Botox for chronic migraine, and are compatible with many acute treatments. Your doctor will build a plan that fits.

Measuring Whether It's Working

The only way to know if a preventive works is to compare your migraine days before and after. Without records, it's easy to misjudge, especially when one bad week colors your memory. Logging attacks in MigraineCast gives you a monthly baseline before you start and a clear comparison afterward. Because the app also tracks weather, you can account for a stormy month that might otherwise make a good treatment look less effective.

Know your baseline before you start a new treatment. Download MigraineCast free on iOS.

Frequently Asked Questions

What does CGRP do in migraine?

CGRP is released by trigeminal nerves during migraine and contributes to blood vessel widening, inflammation, and pain signaling.

How long do CGRP treatments take to work?

Some people notice improvement within the first month, but doctors typically recommend about three months to judge effectiveness.

Are CGRP injections safe?

They were generally well tolerated in clinical trials. Common side effects include injection-site reactions and constipation. Your doctor will review your history, including cardiovascular health and pregnancy plans.

This article is for informational and educational purposes only and is not medical advice. For diagnosis and treatment of migraine, consult a doctor or headache specialist.